TakayukiYamadaMD

PubMed

• 1 citations
  A Specific Target BP in Chronic Kidney Disease Remains Unclear.
  Takayuki Yamada, Chethan M Puttarajappa, Csaba P Kovesdy, Yoshitsugu Obi> ;Journal of the American Society of Nephrology. 2023 Jun 1
• 10 citations
  Cardiovascular and kidney outcomes of combination therapy with sodium-glucose cotransporter-2 inhibitors and mineralocorticoid receptor antagonists in patients with ty...
  Shunichiro Tsukamoto, Ryutaro Morita, Takayuki Yamada, Shingo Urate, Kengo Azushima, Kazushi Uneda, Ryu Kobayashi, Tomohiko Kanaoka, Hiromichi Wakui, Kouichi Tamura> ;Diabetes Research and Clinical Practice. 2022 Dec 1
• 3 citations
  Optimal Anticoagulant Strategy for Periprocedural Management of Atrial Fibrillation Ablation: A Systematic Review and Network Meta-Analysis.
  Tabito Kino, Minako Kagimoto, Takayuki Yamada, Satoshi Ishii, Masanari Asai, Shunichi Asano, Hideto Yano, Toshiyuki Ishikawa, Tomoaki Ishigami> ;Journal of Clinical Medicine. 2022 Mar 28
• 16 citations
  Comparison of effects of SGLT-2 inhibitors and GLP-1 receptor agonists on cardiovascular and renal outcomes in type 2 diabetes mellitus patients with/without albuminur...
  Yuki Kawai, Kazushi Uneda, Takayuki Yamada, Sho Kinguchi, Kazuo Kobayashi, Kengo Azushima, Tomohiko Kanaoka, Yoshiyuki Toya, Hiromichi Wakui, Kouichi Tamura> ;Diabetes Research and Clinical Practice. 2022 Jan 1
• 4 citations
  Tissue-specific expression of the SARS-CoV-2 receptor, angiotensin-converting enzyme 2, in mouse models of chronic kidney disease.
  Shunichiro Tsukamoto, Hiromichi Wakui, Kengo Azushima, Takahiro Yamaji, Shingo Urate, Toru Suzuki, Eriko Abe, Shohei Tanaka, Shinya Taguchi, Takayuki Yamada, Sho Kingu...> ;Scientific Reports. 2021 Aug 19
• Is there a racial disparity in coronavirus disease 2019 patients with chronic kidney disease? An experience in New York City.
  Takayuki Yamada, Takahisa Mikami, Nitin Chopra, Hirotaka Miyashita, Svetlana Chernyavsky, Satoshi Miyashita> ;International Journal of Clinical Practice. 2021 Jul 1
• 11 citations
  Systematic review and meta-analysis for prevention of cardiovascular complications using GLP-1 receptor agonists and SGLT-2 inhibitors in obese diabetic patients
  Kazushi Uneda, Yuki Kawai, Takayuki Yamada, Sho Kinguchi, Kengo Azushima, Tomohiko Kanaoka, Yoshiyuki Toya, Hiromichi Wakui, Kouichi Tamura> ;Scientific Reports. 2021 May 13
• 158 citations
  Risk Factors for Mortality in Patients with COVID-19 in New York City.
  Takahisa Mikami, Hirotaka Miyashita, Takayuki Yamada, Matthew Harrington, Daniel I. Steinberg, Andrew Dunn, Evan Siau> ;Journal of General Internal Medicine. 2021 Jan 1
• 62 citations
  Cardiovascular and renal outcomes with SGLT-2 inhibitors versus GLP-1 receptor agonists in patients with type 2 diabetes mellitus and chronic kidney disease: a systema...
  Takayuki Yamada, Mako Wakabayashi, Abhinav Bhalla, Nitin Chopra, Hirotaka Miyashita, Takahisa Mikami, Hiroki Ueyama, Tomohiro Fujisaki, Yusuke Saigusa, Takahiro Yamaji...> ;Cardiovascular Diabetology. 2021 Jan 7
• 53 citations
  Value of leukocytosis and elevated C-reactive protein in predicting severe coronavirus 2019 (COVID-19): A systematic review and meta-analysis.
  Takayuki Yamada, Mako Wakabayashi, Takahiro Yamaji, Nitin Chopra, Takahisa Mikami, Hirotaka Miyashita, Satoshi Miyashita> ;Clinica Chimica Acta; International Journal of Clinical Chemistry. 2020 Oct 1
• 2 citations
  Effect of renin-angiotensin system blockers on contrast-induced acute kidney injury in patients with normal or mild-to-moderate reduced kidney function undergoing coro...
  Takayuki Yamada, Tomohiro Fujisaki, Nitin Chopra, Takahiro Yamaji, Kengo Azushima, Ryu Kobayashi, Sho Kinguchi, Shingo Urate, Toru Suzuki, Eriko Abe, Hiromichi Wakui, ...> ;Clinical Nephrology. 2020 Sep 1
• 12 citations
  Systematic Review of the Association Between Worsening Renal Function and Mortality in Patients With Acute Decompensated Heart Failure.
  Takayuki Yamada, Hiroki Ueyama, Nitin Chopra, Takahiro Yamaji, Kengo Azushima, Ryu Kobayashi, Sho Kinguchi, Shingo Urate, Toru Suzuki, Eriko Abe, Yusuke Saigusa, Hirom...> ;Kidney International Reports. 2020 Sep 1
• 24 citations
  Impact of dementia on clinical outcomes in elderly patients with coronavirus 2019 (COVID‐19): an experience in New York
  Satoshi Miyashita, Takayuki Yamada, Takahisa Mikami, Hirotaka Miyashita, Nitin Chopra, Dahlia Rizk> ;Geriatrics & Gerontology International. 2020 Jul 1
• 3 citations
  Effects of Erythropoietin-Stimulating Agents on Blood Pressure in Patients with Non-Dialysis CKD and Renal Anemia.
  Kohji Ohki, Hiromichi Wakui, Kazushi Uneda, Kengo Azushima, Kotaro Haruhara, Sho Kinguchi, Shingo Urate, Takayuki Yamada, Takahiro Yamaji, Ryu Kobayashi, Tomohiko Kana...> ;Kidney Diseases. 2020 Jun 12
• 36 citations
  Patients with chronic kidney disease have a poorer prognosis of coronavirus disease 2019 (COVID-19): an experience in New York City.
  Takayuki Yamada, Takahisa Mikami, Nitin Chopra, Hirotaka Miyashita, Svetlana Chernyavsky, Satoshi Miyashita> ;International Urology and Nephrology. 2020 May 26
• 296 citations
  Do patients with cancer have a poorer prognosis of COVID-19? An experience in New York City.
  Hirotaka Miyashita, Takahisa Mikami, Nitin Chopra, Takayuki Yamada, Svetlana Chernyavsky, Dahlia Rizk, Christina Cruz> ;Annals of Oncology. 2020 Apr 21
• A Case of Dual Positive Glomerulonephritis With Plasma Cell Dyscrasia.
  Takayuki Yamada, Hirotaka Miyashita, Mohamed Rizwan Haroon Al Rasheed, Miriam Chung, LiLi, Fadi Salem, Kirk N. Campbell> ;The American Journal of Medicine. 2020 Aug 1
• 5 citations
  Angiotensin II type 1 receptor-associated protein deficiency attenuates sirtuin1 expression in an immortalised human renal proximal tubule cell line.
  Takahiro Yamaji, Akio Yamashita, Hiromichi Wakui, Kengo Azushima, Kazushi Uneda, Yumiko Fujikawa, Sona Haku, Ryu Kobayashi, Kohji Ohki, Kotaro Haruhara, Sho Kinguchi, ...> ;Scientific Reports. 2019 Nov 12
• 24 citations
  Improved home BP profile with dapagliflozin is associated with amelioration of albuminuria in Japanese patients with diabetic nephropathy: the Yokohama add-on inhibito...
  Sho Kinguchi, Hiromichi Wakui, Yuzuru Ito, Yoshinobu Kondo, Kengo Azushima, Uru Nezu Osada, Tadashi Yamakawa, Tamio Iwamoto, Jun Yutoh, Toshihiro Misumi, Kazutaka Aoki...> ;Cardiovascular Diabetology. 2019 Aug 27
• 8 citations
  Effects of ATRAP in Renal Proximal Tubules on Angiotensin-Dependent Hypertension.
  Sho Kinguchi, Hiromichi Wakui, Kengo Azushima, Kotaro Haruhara, Tomoyuki Koguchi, Kohji Ohki, Kazushi Uneda, Miyuki Matsuda, Sona Haku, Takahiro Yamaji, Takayuki Yamad...> ;Journal of the American Heart Association. 2019 Apr 16
• 20 citations
  Early Enhanced Leucine-Rich α-2-Glycoprotein-1 Expression in Glomerular Endothelial Cells of Type 2 Diabetic Nephropathy Model Mice.
  Sona Haku, Hiromichi Wakui, Kengo Azushima, Kotaro Haruhara, Sho Kinguchi, Kohji Ohki, Kazushi Uneda, Ryu Kobayashi, Miyuki Matsuda, Takahiro Yamaji, Takayuki Yamada, ...> ;Biomed Research International. 2018 Nov 1
• 1 citations
  An interesting cross-talk between the glucagon-like peptide-1 receptor axis and angiotensin receptor pathway for modulation of renal sodium handling in obesity
  Kouichi Tamura, Takahiro Yamaji, Takayuki Yamada, Masato Ohsawa, Hiromichi Wakui> ;Hypertension Research. 2018 Aug 15
• 15 citations
  Angiotensin II Type 1 Receptor-associated Protein Inhibits Angiotensin II-induced Insulin Resistance with Suppression of Oxidative Stress in Skeletal Muscle Tissue
  Kohji Ohki, Hiromichi Wakui, Nozomu Kishio, Kengo Azushima, Kazushi Uneda, Sona Haku, Ryu Kobayashi, Kotaro Haruhara, Sho Kinguchi, Takahiro Yamaji, Takayuki Yamada, S...> ;Scientific Reports. 2018 Feb 12
• Join now to see all

Lectures

• The short-term outcomes from TOP-G trial: Ramdomized phase II noninferiority trial comparing gastrectomy with omentectomy and omentum preserving gastrectomy for advanc... 
  ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/23/2020